# Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)

> **NCT02978118** · — · ACTIVE_NOT_RECRUITING · sponsor: **Duke University** · enrollment: 67 (actual)

## Conditions studied

- Carcinoma, Renal Cell
- Carcinoma, Urothelial

## Interventions

- **DEVICE:** Immune cell and CTC detection procedures

## Key facts

- **NCT ID:** NCT02978118
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-03-07
- **Primary completion:** 2028-10
- **Final completion:** 2028-10
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2025-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02978118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02978118, "Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02978118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*